Skip to main content
OpenTrials
Completed

NCT Number: NCT00790530

Automated Telephone Outreach With Speech Recognition to Improve Diabetes Care: A Randomized Controlled Study

The purpose of this study is to evaluate the effectiveness of automated telephone outreach with speech recognition to improve diabetes care.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Harvard Pilgrim Health Care

Boston, Massachusetts, 02215, United States

About this study

Randomly allocate a total of 1200 health plan members with diabetes to automated telephone outreach with speech recognition (ATO-SR; N = 600) or usual care (N = 600). The intervention is a series of three calls, using automated calls, originating from the health plan, using interactive speech recognition technology, spaced approximately 4-6 weeks apart, to encourage participants to fulfill the recommended testing (dilated eye examinations, glycated hemoglobin, LDL-cholesterol, microalbumin) that had not been performed received in the preceding year.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age 18 years or older
  • Diabetes, defined as either 1) filled a prescription for insulin or an oral hypoglycemic agent; or, 2) had two outpatient or one inpatient or two outpatients encounter claims with an ICD9-CM or CPT code indicating diabetes.
  • Gap in a key diabetes management metric as evidenced by no claim for a dilated eye examination in the prior 15 months and no claim for one or more of the following tests: glycated hemoglobin, LDL-cholesterol, or microalbumin. (Individuals with evidence of having received ACE-inhibitors or angiotensin receptor blockers were considered to have had a microalbumin test.)

Exclusion criteria

  • No primary care clinician in the data base
  • Those who had previously asked the health plan to exclude them from research or quality improvement
  • Women whose claim records contained diagnoses suggesting gestational diabetes

Treatment and study plan

Automated Telephone Outreach with Speech Recognition

Behavioral

Automated Telephone Outreach with Speech Recognition

Usual Care

Other

Usual Care

Primary outcomes

  1. Completion of dilated eye examination

    Time frame: 12-months following intervention

Secondary outcomes

  1. Completion of glycated hemoglobin testing (HbA1c)

    Time frame: one-year following intervention

  2. Completion of LDL-cholesterol testing

    Time frame: one year following intervention

  3. Completion of microalbumin testing

    Time frame: one-year following intervention

Sponsors and collaborators

Lead sponsor

Harvard Pilgrim Health Care

Other

Collaborators

  • American Diabetes Association

Registry information

Acronym: ATO-SR-DM

Important dates

Study start
2006
Primary completion
2007
Study completion
2007
First posted
Nov 13, 2008
Registry last updated
Nov 13, 2008

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.